Neoplasm of Uncertain Histogenesis — Trials

Neoplasm of Uncertain Histogenesis — Trials · CancerIndex

Clinical trials

Registered studies

91,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 12,651–12,700 of 13,361 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00101816	Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate	completed	Phase 2	124	Bristol-Myers SquibbINDUSTRY	20	Aug 10, 2010	clinicaltrials
NCT00103844	Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia	completed	Phase 2	150	Bristol-Myers SquibbINDUSTRY	32	Aug 10, 2010	clinicaltrials